Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eberhard Schulz

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Journal of the American College of Cardiology|November 22, 2008
NOX5, a new "radical" player in human atherosclerosis?Eberhard Schulz, Thomas Münzel
Circulation|October 26, 2011
Intracellular pH: a fundamental modulator of vascular functionEberhard Schulz, Thomas Münzel
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|September 24, 2016
Eberhard Schulz, Christian Fleischhaker
Pharmazie in Unserer Zeit|September 7, 2010
[Treatment of coronary heart disease with nitric oxide donors]Thomas Münzel, Eberhard Schulz
Hypertension (Dallas, Tex. : 1979)|January 20, 2016
Lumen Size Matters: Role of Protein Disulfide Isomerase A1 in Vascular RemodelingEberhard Schulz, Thomas Münzel
Pharmazie in Unserer Zeit|October 27, 2011
[α2-Adrenergic agonists, and drugs for ADHD]Hans-Willi Clement, Eberhard Schulz
JACC. Cardiovascular Interventions|September 22, 2014
Immediate, acute, and subacute thrombosis due to incomplete expansion of bioresorbable scaffoldsTommaso Gori, Eberhard Schulz, Thomas Münzel
Hypertension (Dallas, Tex. : 1979)|August 19, 2009
Protein kinase C-inhibiting properties of the losartan metabolite EXP3179 make the differencePhilip Wenzel, Eberhard Schulz, Thomas Münzel
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 23, 2011
Oxidative stress and endothelial dysfunction in hypertensionEberhard Schulz, Tommaso Gori, Thomas Münzel
Circulation Research|February 28, 2009
When metabolism rules perfusion: AMPK-mediated endothelial nitric oxide synthase activationEberhard Schulz, Swenja Schuhmacher, Thomas Münzel
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Journal of the American College of Cardiology|November 22, 2008
NOX5, a new "radical" player in human atherosclerosis?Eberhard Schulz, Thomas Münzel
Circulation|October 26, 2011
Intracellular pH: a fundamental modulator of vascular functionEberhard Schulz, Thomas Münzel
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|September 24, 2016
Eberhard Schulz, Christian Fleischhaker
Pharmazie in Unserer Zeit|September 7, 2010
[Treatment of coronary heart disease with nitric oxide donors]Thomas Münzel, Eberhard Schulz
Hypertension (Dallas, Tex. : 1979)|January 20, 2016
Lumen Size Matters: Role of Protein Disulfide Isomerase A1 in Vascular RemodelingEberhard Schulz, Thomas Münzel
Pharmazie in Unserer Zeit|October 27, 2011
[α2-Adrenergic agonists, and drugs for ADHD]Hans-Willi Clement, Eberhard Schulz
JACC. Cardiovascular Interventions|September 22, 2014
Immediate, acute, and subacute thrombosis due to incomplete expansion of bioresorbable scaffoldsTommaso Gori, Eberhard Schulz, Thomas Münzel
Hypertension (Dallas, Tex. : 1979)|August 19, 2009
Protein kinase C-inhibiting properties of the losartan metabolite EXP3179 make the differencePhilip Wenzel, Eberhard Schulz, Thomas Münzel
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 23, 2011
Oxidative stress and endothelial dysfunction in hypertensionEberhard Schulz, Tommaso Gori, Thomas Münzel
Circulation Research|February 28, 2009
When metabolism rules perfusion: AMPK-mediated endothelial nitric oxide synthase activationEberhard Schulz, Swenja Schuhmacher, Thomas Münzel
Pageof 16